Pathogenesis of atherosclerosis in diabetes and hypertension

Clinical and Experimental Hypertension

Volumn 21, Issue 1-2, 1999, Pages 69-77

  Shantaram, V ^a  

^a NIZAM'S INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Atherosclerosis; Central obesity; Dyslipidemia; Hyperinsulinemia; Hypertension; Insulin resistance

Indexed keywords

ATHEROGENESIS; CONFERENCE PAPER; CORONARY ARTERY ATHEROSCLEROSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERINSULINISM; HYPERLIPIDEMIA; HYPERTENSION; NONHUMAN; OBESITY; RISK FACTOR; SMOKING CESSATION; TREATMENT PLANNING; WEIGHT REDUCTION;

EID: 0033046853     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969909068650     Document Type: Conference Paper

References (16)

1. Pyorala K., Laakso M., Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev. 1987; 3: 463-524.
2. Kannel W. B., McGee D. L. Diabetes and Cardiovascular disease: the Framingham study. JAMA. 1979; 241: 2035-2038.
3. Howard B. V. Lipoprotein metabolism in diabetes mellitus. J Lipid Res. 1987; 28: 613-628.
4. West K. M., Ahuja M. M. S., Bennett P. H. et.al. The role of ciruclating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care. 1983; 6: 361-369.
5. Laakso M., Voutlainen E., Pyorala K., Sarlund H. Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics. Arteriosclerosis. 1985; 5: 653-658.
6. Takegoshi T., Haba T., Hirai J., et.al. Alterations of lipoprotein(a) in patients with diabetic nephropathy (Letter). Atherosclerosis. 1990; 83: 99-100.
7. Brunzell J. D., Sniderman A. D., Albers J. J., Kwiterovich P. O., Jr. Apoproteins B and A-1 coronary artery disease in humans. Arteriosclerosis. 1984; 4: 79-83.
8. DeFronzo R. A., Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care. 1991; 14: 173-194.
9. Kaplan N. M. The deadly quatlet upper body obesity glucose intolerance hypertriglyceridemia and hypertension. Arch Intern Med. 1989; 149: 1514-1520.
10. Fuljioka S., Matsuzawa Y., Tokunaga K., Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987; 36: 54-59.
11. Reaven G. M. Insulin resistance, hyperinsullinemia hypertriglyceridemia and hypertension parallels between human disease and rodent models. Diabetes Care. 1991; 14: 195-202.
12. LePape A., Guitton, J. D., Gutman N., et.al. Nonenzymatic glucosylation of collagen in diabetes: incidence on increased normal platelet aggregation. Haemostasis. 1983; 13: 36-41.
13. Kirstein M., Brett J., Radoff S., et.al. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA. 1990; 87:9010-9014.
14. Vlassara H., Brownlee M., Manogue K. R., et. al. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelling. Science. 1988; 240: 1546-1548.
15. Kitahara M., Eyre H. J., Lynch R. E., et. al. Metabolic activity of diabetic monocytes. Diabetes. 1980; 29: 251-256
16. Witztum J. L., Koschinsky T. Metabolic and immunological consequences of glycation of low density lipoproteins. Prog Clin Biol Res. 1989; 304: 219-234.